AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值

目的研究AFP、CA19-9、CEA联合检测对原发性肝癌进行早期诊断的临床价值。方法收集2014年10月-2016年12月东南大学附属第二医院门诊和住院的肝病患者248例,分为原发性肝癌组(n=88)和非肿瘤性肝病组(n=160),另选取130例健康体检者为正常对照组。采用Roche cobas e 411 analyzer检测3组患者的血清肿瘤标志物AFP、CA19-9、CEA水平,分析3种肿瘤标志物单个检测和联合检测的灵敏度和特异度。采用Beckman Coulter AU5800检测肝功能生化指标。采用Biotek ELX808检测HBV血清学标志物和HCV抗体。应用受试者工作特征曲线(...

Full description

Saved in:
Bibliographic Details
Published in临床肝胆病杂志 Vol. 33; no. 7; pp. 1291 - 1295
Main Author 李嘉妍 宋金云 王建芳 吴旭平
Format Journal Article
LanguageChinese
Published 东南大学附属第二医院 临床科研中心,南京,210003 2017
Subjects
Online AccessGet full text
ISSN1001-5256
DOI10.3969/j.issn.1001-5256.2017.07.017

Cover

More Information
Summary:目的研究AFP、CA19-9、CEA联合检测对原发性肝癌进行早期诊断的临床价值。方法收集2014年10月-2016年12月东南大学附属第二医院门诊和住院的肝病患者248例,分为原发性肝癌组(n=88)和非肿瘤性肝病组(n=160),另选取130例健康体检者为正常对照组。采用Roche cobas e 411 analyzer检测3组患者的血清肿瘤标志物AFP、CA19-9、CEA水平,分析3种肿瘤标志物单个检测和联合检测的灵敏度和特异度。采用Beckman Coulter AU5800检测肝功能生化指标。采用Biotek ELX808检测HBV血清学标志物和HCV抗体。应用受试者工作特征曲线(ROC曲线)对原发性肝癌患者的血清AFP、CA19-9、CEA及3者联合检测结果进行分析评价。计量资料多组间比较采用单因素方差分析,进一步两两比较采用SNK-q检验,2组间比较采用t检验;计数资料组间比较采用χ~2检验。相关性分析采用Spearman分析。结果在原发性肝癌组和非肿瘤性肝病组中,肝功能异常患者的AFP、CA19-9均显著高于肝功能正常组(原发性肝癌组:t值分别为35.64、3.38,P值均〈0.05;非肿瘤性肝病组:t值分别为12.51、8.19,P值均〈0.05);原发性肝癌组中肝功能正常患者的CEA均明显高于非肿瘤性肝病组中肝功能正常患者和正常对照组(P值均〈0.05);原发性肝癌组中肝功能异常患者的AFP、CA19-9、CEA水平均明显高于非肿瘤性肝病组中的肝功能异常患者和正常对照组(P值均〈0.05)。血清AFP、CA19-9、CEA水平随Child Pugh分级的升高而升高,在原发性肝癌组肝功能异常患者中,AFP、CA19-9、CEA水平B级较A级,C级较B级均显著升高(P值均〈0.05);在非肿瘤性肝病组肝功能异常患者中,AFP、CA19-9水平B级较A级,C级较B级均显著升高(P值均〈0.05),CEA水平C级显著高于A、B级(P值均〈0.05)。原发性肝癌组AFP、CA19-9、CEA的阳性率高于非肿瘤性肝病组和正常对照组(P值均〈0.05);各组的联合检测阳性率显著高于单项检测阳性率(P值均〈0.05)。原发性肝癌组中,三项联合检测的灵敏度和特异度分别为86.36%和92.35%,单项检测中AFP、CA19-9、CEA的灵敏度分别为71.59%、52.27%和39.77%,原发性肝癌患者的血清
Bibliography:liver neoplasms; alpha-fetoproteins; CA-19-9 antigen; carcinoembryonic antigen; diagnosis
LI Jiayan, SONG Jinyun, WANG Jianfang, et al. ( Clinical Research Center, The Second Affiliated Hospital of Southeast University, Nanjing 210003, China)
Objective To investigate the value of combined measurement of alpha-fetoprotein(AFP),carbohydrate antigen 19-9(CA19-9),and carcinoembryonic antigen(CEA) in the early diagnosis of primary liver cancer.Methods A total of 248 patients who visited the outpatient service or were hospitalized in The Second Hospital of Nanjing from October 2014 to December 2016 were enrolled and divided into primary liver cancer group with 88 patients and non-tumor liver disease group with 160 patients.A total of 130 healthy subjects who underwent physical examination were enrolled as normal control group.The Roche cobas e 411 analyzer was used to measure the serum levels of the tumor markers AFP,CA19-9,and CEA,and the sensitivities and specificities of these markers or a combination of them were
ISSN:1001-5256
DOI:10.3969/j.issn.1001-5256.2017.07.017